Walter B. Jones

2.0k total citations
57 papers, 1.5k citations indexed

About

Walter B. Jones is a scholar working on Reproductive Medicine, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Walter B. Jones has authored 57 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Reproductive Medicine, 19 papers in Surgery and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Walter B. Jones's work include Ovarian cancer diagnosis and treatment (23 papers), Gestational Trophoblastic Disease Studies (17 papers) and Endometrial and Cervical Cancer Treatments (12 papers). Walter B. Jones is often cited by papers focused on Ovarian cancer diagnosis and treatment (23 papers), Gestational Trophoblastic Disease Studies (17 papers) and Endometrial and Cervical Cancer Treatments (12 papers). Walter B. Jones collaborates with scholars based in United States and United Kingdom. Walter B. Jones's co-authors include John L. Lewis, Stephen C. Rubin, William J. Hoskins, Thomas B. Hakes, Lois Almadrones, Niels H. Lauersen, John P. Curtin, Maurie Markman, Bonnie Reichman and Hugh M. Shingleton and has published in prestigious journals such as Cancer, American Journal of Obstetrics and Gynecology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Walter B. Jones

55 papers receiving 1.4k citations

Peers

Walter B. Jones
C. W. E. Redman United Kingdom
Leon L. Adcock United States
L.C. Wong Hong Kong
Herbert J. Buchsbaum United States
J. H. Shepherd United Kingdom
C. W. E. Redman United Kingdom
Walter B. Jones
Citations per year, relative to Walter B. Jones Walter B. Jones (= 1×) peers C. W. E. Redman

Countries citing papers authored by Walter B. Jones

Since Specialization
Citations

This map shows the geographic impact of Walter B. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter B. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter B. Jones more than expected).

Fields of papers citing papers by Walter B. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter B. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter B. Jones. The network helps show where Walter B. Jones may publish in the future.

Co-authorship network of co-authors of Walter B. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Walter B. Jones. A scholar is included among the top collaborators of Walter B. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter B. Jones. Walter B. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markman, Maurie, John L. Lewis, Patricia E. Saigo, et al.. (2010). Epithelial ovarian cancer in the elderly: The memorial sloan-kettering cancer center experience. Cancer. 71(S2). 634–637. 14 indexed citations
2.
Schechter, Naomi R., Borys Mychalczak, Walter B. Jones, & David R. Spriggs. (1998). Prognosis of Patients Treated with Whole-Brain Radiation Therapy for Metastatic Gestational Trophoblastic Disease. Gynecologic Oncology. 68(2). 183–192. 24 indexed citations
3.
Russell, Anthony H., Hugh M. Shingleton, Walter B. Jones, et al.. (1998). Trends in the use of radiation and chemotherapy in the initial management of patients with carcinoma of the uterine cervix. International Journal of Radiation Oncology*Biology*Physics. 40(3). 605–613. 16 indexed citations
4.
Hicks, Michael L., Jerri Linn Phillips, Groesbeck P. Parham, et al.. (1998). The National Cancer Data Base report on endometrial carcinoma in African-American women. Cancer. 83(12). 2629–2637. 79 indexed citations
5.
Russell, Anthony H., Walter B. Jones, Amy M. Fremgen, et al.. (1996). Diagnostic Assessments in Patients with Invasive Cancer of the Cervix: A National Patterns of Care Study of the American College1of Surgeons. Gynecologic Oncology. 63(2). 159–165. 26 indexed citations
6.
Vaccarello, Luis, Stephen C. Rubin, Vaia Vlamis, et al.. (1995). Cytoreductive Surgery in Ovarian Carcinoma Patients with a Documented Previously Complete Surgical Response. Gynecologic Oncology. 57(1). 61–65. 109 indexed citations
7.
Jones, Walter B., Hugh M. Shingleton, Anthony H. Russell, et al.. (1995). Patterns of care for invasive cervical cancer. Results of a national survey of 1984 and 1990. Cancer. 76(S10). 1934–1947. 34 indexed citations
8.
Markman, Maurie, Bonnie Reichman, Thomas B. Hakes, et al.. (1993). The Use of Recombinant Human Erythropoietin to Prevent Carboplatin-Induced Anemia. Gynecologic Oncology. 49(2). 172–176. 29 indexed citations
9.
Jones, Walter B., et al.. (1993). Late Recurrence of Clear Cell Adenocarcinoma of the Vagina and Cervix: A Report of Three Cases. Gynecologic Oncology. 51(2). 266–271. 15 indexed citations
10.
Jones, Walter B.. (1993). Cutaneous Larva Migrans. Southern Medical Journal. 86(11). 1311–1313. 7 indexed citations
11.
Jones, Walter B., et al.. (1993). Thoracotomy in the management of gestational choriocarcinoma. A clinicopathologic study. Cancer. 72(7). 2175–2181. 36 indexed citations
12.
Reichman, Bonnie, Maurie Markman, Thomas B. Hakes, et al.. (1993). Mitomycin-C Plus a 3-Day Continuous Intravenous Infusion of 5-Fluorouracil: An Inactive Salvage Regimen for Platinum-Resistant Ovarian Carcinoma. Gynecologic Oncology. 50(1). 30–33.
13.
Markman, Maurie, Linda C. DeMarco, Martin Birkhofer, et al.. (1993). Phase II trial of zeniplatin (CL 286 558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy. Journal of Cancer Research and Clinical Oncology. 119(4). 234–236. 5 indexed citations
14.
Markman, Maurie, John L. Lewis, Patricia E. Saigo, et al.. (1993). Impact of Age on Survival of Patients with Ovarian Cancer. Gynecologic Oncology. 49(2). 236–239. 37 indexed citations
15.
Markman, Maurie, Bonnie Reichman, Thomas B. Hakes, et al.. (1992). Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer. Gynecologic Oncology. 47(3). 353–357. 10 indexed citations
16.
Hakes, Thomas B., W.J. Hoskins, Walter B. Jones, et al.. (1992). Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma. Gynecologic Oncology. 45(3). 284–289. 120 indexed citations
17.
Markman, Maurie, Bonnie Reichman, Thomas B. Hakes, et al.. (1992). Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy. Journal of Cancer Research and Clinical Oncology. 118(5). 391–394. 1 indexed citations
18.
Chaganti, RS, Prasad Koduru, Ranajit Chakraborty, & Walter B. Jones. (1990). Genetic origin of a trophoblastic choriocarcinoma.. PubMed. 50(19). 6330–3. 15 indexed citations
19.
Rubin, Stephen C., William J. Hoskins, Walter B. Jones, et al.. (1990). Aggressive chemosurgical debulking in patients with advanced ovarian cancer. Gynecologic Oncology. 38(3). 358–363. 26 indexed citations
20.
Jones, Walter B. & John L. Lewis. (1974). Treatment of gestational trophoblastic disease. American Journal of Obstetrics and Gynecology. 120(1). 14–20. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026